TADAMITSU KISHIMOTO
Patent Owner
Stats
- 13 total patents issued
- 0 Total Apps Published
- Feb 21, 2012 most recent publication
Details
- 13 Issued Patents
- 1 Issued in last 3 years
- 0 Published in last 3 years
- 154 Total Citation Count
- Jun 15, 1989 Earliest Filing
- 4 Expired/Abandoned/Withdrawn Patents
Technologies
Intl Class
Technology
# of Patents
Rank
Top Patents (by citation)
Patent #
Title
Filing Date
Issue Date
Intl Class
Cited #
5,888,510 Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective componentApr 07, 97Mar 30, 99[A01N, A61K, C07K]38
6,034,235 Growth inhibitor for leukemia cell comprising antisense oligonucleotide derivative to wilms tumor gene (WT1)Dec 01, 97Mar 07, 00[C07H]30
6,277,832 Growth inhibitor for leukemia cells comprising antisense oligonucleotide derivative to wilms tumor gene (wt1)Jan 20, 00Aug 21, 01[C12N, C07H, A61K]25
6,723,319 Method of treating inflammatory intestinal diseases containing as the ingredient IL-6 receptors antibodiesSep 14, 00Apr 20, 04[A61K]19
5,541,088 Recombinant process of producing non-glycosylated B-cell defferentiation factorSep 21, 94Jul 30, 96[C12N, C07K]3
5,362,489 Use of recombinant B-cell differentiation factor for augmenting antibody production and stimulating bone marrow proliferationMay 04, 92Nov 08, 94[A61K]2
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
7,247,424 Screening method for a substance having hypoglycemic activity by using STAT-induced inhibitor of STAT function-1Sep 11, 01Jul 24, 07[C12Q]
6,723,319 Method of treating inflammatory intestinal diseases containing as the ingredient IL-6 receptors antibodiesSep 14, 00Apr 20, 04[A61K]
6,277,832 Growth inhibitor for leukemia cells comprising antisense oligonucleotide derivative to wilms tumor gene (wt1)Jan 20, 00Aug 21, 01[C12N, C07H, A61K]
6,034,235 Growth inhibitor for leukemia cell comprising antisense oligonucleotide derivative to wilms tumor gene (WT1)Dec 01, 97Mar 07, 00[C07H]
5,888,510 Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective componentApr 07, 97Mar 30, 99[A01N, A61K, C07K]
5,541,088 Recombinant process of producing non-glycosylated B-cell defferentiation factorSep 21, 94Jul 30, 96[C12N, C07K]
5,362,489 Use of recombinant B-cell differentiation factor for augmenting antibody production and stimulating bone marrow proliferationMay 04, 92Nov 08, 94[A61K]
Top Inventors for This Owner
Inventor Name
Address
# of Patent/Pub
